Antidiabetic Potency of Flavonoids Using a Systematic Computer-Aided Drug Design Platform
Journal Title: International Journal of Experimental Research and Review - Year 2024, Vol 40, Issue 4
Abstract
Diabetic mellitus (DM) is a chronic metabolic disorder, with type 2 diabetes (T2DM) being the most prevalent type globally. Despite the availability of several target-specific drugs, the prevalence rate has remained uncontrollable, prompting a systematic exploration of plant secondary metabolites or phytochemicals for mainstream use. Among all natural resources, citrus fruits like oranges, lemons, grapefruits and limes are rich sources of flavonoids and get more attention due to their higher antioxidant, anti-inflammatory and immunomodulatory effects. Additionally, researchers have employed various strategies to locate the most bioactive and drug-able flavonoids from these herbal extracts for use in managing diabetes. Therefore, the present study selected nine citrus-fruit-derived flavonoids and tested their antidiabetic potency using four target enzymes: α-amylase, AKT Serine/Threonine Kinase 1 (AKT1), dipeptidyl peptidase-4 (DPP-IV), and glucose transporter 1 (GLU1) through molecular docking studies. In addition, we have predicted the physiochemical profile, toxicity, bioavailability, lead-likeness, drug-likeness, and lethal dose of flavonoids, along with five standard antidiabetic drugs, to select the most potential candidates. We used AutoDock 4.2 for the docking study, BIOVID-Discovery Studio for the protein-ligand interaction study, SwissADME, ProTox 3.0 and Molsot tools to predict the drug-likeness profile. Individual and average docking scores indicated that naringin (-11.2 and -10.40 kcal/mol) was the most potent flavonoid, and glimepiride (-11.1 and -10.1 kcal/mol) against AKT1 had the most potential among the five antidiabetic drugs. Naringin had non-toxic profiles, a positive drug-likeness score, and ideal physicochemical profiles, which suggested that it might be the best candidate for further testing. To sum up, the computer-aided drug design platform is an important part of the current drug discovery module to accelerate phyto-based drug discovery within limited time and resources.
Authors and Affiliations
Deepankar Rath, Gurudutta Pattnaik, Biswakanth Kar, Gopal Krishna Padhy, Chandrasekhar Patro and Pallishree Bhukta
Keywords
Related Articles
- EP ID EP739940
- DOI 10.52756/ijerr.2024.v40spl.020
- Views 50
- Downloads 1
Role of Technology Innovation in Economic Growth: A Bibliometric Analysis
Economic growth is a metric used to measure a country's development and advancement. Technological innovation is a driving force behind economic growth and helps to improve and modernize industrial techniques. Thus, this...
Computational Thinking Processes in Solving the Corona Epidemic Model: Pre-service Maths Teachers
In the 21st century, pre-service mathematics teachers are expected to have problem-solving skills that are effective, efficient, and solutive and are in line with the mindset of computer experts. In learning mathematics,...
Effect of capsular stretch on frozen shoulder
Frozen shoulder is a chronic disabling disease of the shoulder. The management of the frozen shoulder are numerous, but the studies show their own limitation. Biomechanically, it was noted that the cause of the frozen sh...
A review on opportunities and challenges of nitrogen removal from wastewater using microalgae
This study provides information on the occurrence of nitrogenous contamination in surface water, their sources and their negative effects. In addition, the study gives an overview of the possible technical, institutional...
Evaluation of Pulmonary Status of Post-Tuberculosis Patients with Spirometry and Chest X-Ray
In 2022, 7.5 million new cases of tuberculosis were reported worldwide. Mycobacterium tuberculosis results in tuberculosis, an infectious disease mostly affecting the lungs. However, many completely treated post-tubercul...